Form4insider filings, from the source

SEC Form 4 · accession 0001062993-18-003493

BIOSPECIFICS TECHNOLOGIES CORP · BSTC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 18, 2016
Accepted (ET)
Aug 17, 2018 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.001 par valueMay 18, 2016S50$33.80D1,005,128D
Common Stock, $0.001 par valueMay 18, 2016S150$33.14D1,004,978D
Common Stock, $0.001 par valueMay 18, 2016S50$34.11D1,004,928D
Common Stock, $0.001 par valueMay 18, 2016S24,750$33.00D980,178D
Common Stock, $0.001 par valueF1Aug 29, 2016S1,607$37.6107D978,571D
Common Stock, $0.001 par valueF2Aug 30, 2016S2,692$37.5027D975,879D
Common Stock, $0.001 par valueF3Sep 1, 2016S7,935$37.533D967,944D
Common Stock, $0.001 par valueSep 2, 2016S1,266$37.50D966,678D
Common Stock, $0.001 par valueF4Sep 13, 2016S3,605$37.545D963,073D
Common Stock, $0.001 par valueF5Sep 15, 2016S3,100$41.21D959,973D
Common Stock, $0.001 par valueF6Nov 29, 2016S10,000$48.0832D949,973D
Common Stock, $0.001 par valueF7Aug 17, 2018S2,500$51.8912D947,473D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses